Nyxoah SA (NYXH) vs Quanterix (QTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Quanterix (QTRX) has outperformed Nyxoah SA (NYXH) over the past year, losing 46.5% versus a loss of 77.9%. Over five years, QTRX leads with a -93.8% price change compared with -94.7% for NYXH. Quanterix is the larger company by market cap ($155.1 million vs $138.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NYXH | QTRX |
|---|---|---|
| Share price | $1.36 | $3.28 |
| Market cap | $138.50M | $155.12M |
| 1-day change | +0.74% | +2.18% |
| YTD return | -70.65% | -49.53% |
| 1-year return | -77.87% | -46.50% |
| 5-year return | -94.71% | -93.79% |
| EPS (TTM) | $-2.56 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.88 | $8.77 |
| 52-week low | $1.26 | $2.15 |
| Distance from 52-week high | -80.22% | -62.60% |
| Analyst consensus | none | none |
| Avg. price target upside | +208.82% | -8.54% |
| Average volume | 275.85K | 764.39K |
| Shares outstanding | 101.84M | 47.29M |
| Employees | 153 | 450 |
| Sector | Health Care | Industrials |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QTRX has outperformed NYXH by 31.4 percentage points over the past year.
- The two companies sit in different sectors: Nyxoah SA in Health Care and Quanterix in Industrials.
About Nyxoah SA
NYXH stock →Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Health Care · Medical/Dental Instruments · 153 employees
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
NYXH vs QTRX FAQ
Which is bigger, Nyxoah SA or Quanterix?
Quanterix (QTRX) is larger, with a market capitalization of $155.12M compared with $138.50M for Nyxoah SA (NYXH).
Which stock has performed better over the past year, NYXH or QTRX?
QTRX returned -46.50% over the past 12 months, compared with -77.87% for NYXH (price return, excluding dividends). Past performance does not predict future results.
Are Nyxoah SA and Quanterix in the same industry?
No. Nyxoah SA is in the Health Care sector, while Quanterix is in Industrials.